Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shigeo Horie, M.D."'
Autor:
Takeshi Ieda, M.D., Ph.D., Satoru Muto, M.D., Ph.D., Fumitaka Shimizu, M.D., Ph.D., Masataka Taguri, M.D., Ph.D., Shigeto Yanada, M.D., Kousuke Kitamura, M.D., Ph.D., Kazutaka Terai, M.D., Ph.D., Keisuke Saito, M.D., Ph.D., Tatsuya Ogishima, M.D., Ph.D., Masayoshi Nagata, M.D., Ph.D., Hisamitsu Ide, M.D., Ph.D., Takatsugu Okegawa, M.D., Ph.D., Yoshiaki Wakumoto, M.D., Ph.D., Yoshiro Sakamoto, M.D., Ph.D., Akira Tsujimura, M.D., Ph.D., Raizo Yamaguchi, M.D., Ph.D., Kikuo Nutahara, M.D., Shigeo Horie, M.D.
Publikováno v:
EBioMedicine, Vol 12, Iss C, Pp 98-104 (2016)
Background: Some risk classifications to determine prognosis of patients with non-muscle invasive bladder cancer (NMIBC) have disadvantages in the clinical setting. We investigated whether the EORTC (European Organization for Research and Treatment o
Externí odkaz:
https://doaj.org/article/1f5e05e10ded4941b001a8f5af204f25
